Open AccessAccelerated neuromodulation therapy for Obsessive-Compulsive Disorder
Author(s) -
Nolan Williams,
Keith Sudheimer,
Eleanor Cole,
Andrea Varias,
Andrea GoldsteinPiekarski,
Patrick Stetz,
Anthony Lombardi,
Maria Filippou-Frye,
Peter van Roessel,
Kelley Anderson,
Elizabeth A. McCarthy,
Brianna Wright,
Thasveen Sandhu,
Sindu Me,
Booil Jo,
Lorrin Koran,
Leanne M. Williams,
Carolyn I. Rodríguez
Publication year - 2021
Publication title -
brain stimulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.685
H-Index - 81
eISSN - 1935-861X
pISSN - 1876-4754
DOI - 10.1016/j.brs.2021.02.013
Subject(s) - neuromodulation , obsessive compulsive , psychotherapist , psychology , medicine , psychiatry , neuroscience , central nervous system
The open-label trial of Williams, Sudheimer, Cole, et al., suggests safety, feasibility, and high efficacy for treatment-refractory OCD of an accelerated, fMRI-guided, high-dose, cTBSmod protocol targeting the right frontal pole. Larger, randomized, controlled trials are needed to test the promising results of this pilot study. CLINICALTRIALS.GOV REGISTRY NUMBERS: NCT03404609.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom